CEP55 and urinary bladder cancer: Mounting evidence shows that CEP55 is highly expressed in multiple cancers, such as colon cancer, hepatocellular carcinoma and bladder cancer (Gao & Wang, 2015; Li et al., 2018b; Singh et al., 2015).